Zadifen 1mg

Tablet
Ketotifen Fumarate (Oral)
Unimed Unihealth MFG. Ltd

Other Strength:

Alternative:
- Ketomar 1mg
- Alarid 1mg
- Prosma 1mg
- Tosma 1mg
- Stafen 1mg
- Ketocure 1mg
- Tofen 1mg
- Totifen 1mg



Zadifen
Presentation
Zadifen tablet: Yellow, round-shaped tablet; each tablet contains Ketotifen Fumarate BP 1.38 mg equivalent to Ketotifen 1 mg.
Zadifen syrup: Clear, colourless, lemon-flavoured syrup; each 5 ml syrup contains Ketotifen Fumarate BP 1.38 mg equivalent to Ketotifen 1 mg.

Indication
– Symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.
– Long term prevention of bronchial asthma; allergic bronchitis; asthmatic symptoms associated with hay fever. In the prevention of bronchial asthma it may take several weeks of treatment to achieve the full therapeutic effect.
– Prevention and treatment of multisystem allergies; allergic skin reactions.

Dosage and administration
Adults: 1 mg (one tablet or 5 ml spoonful syrup) twice daily with food. If necessary the dose may be increased to 2 mg (two tablets or 5 ml 2 spoonful syrup) twice daily.
Children aged 3 years and above: 1 mg (5 ml spoonful syrup) twice daily with food.
Children aged 6 months to 3 years: 0.5 mg (2.5 ml spoonful syrup) twice daily with food.

Contra-indications, warnings, etc.
Contra-indications: Ketotifen tablet and syrup are contra-indicated in patients with known hypersensitivity to Ketotifen.

Warnings and precautions:
Convulsions have been reported very rarely during Ketotifen therapy. As Ketotifen may lower the seizure threshold it should be used with caution in patients with a history of epilepsy.

Effects on ability to drive and use machines:
During the first few days of treatment with Ketotifen reactions may be impaired. Patients should be warned not
to take charge of vehicles or machinery during Ketotifen treatment.

Drug interactions:
Ketotifen may potentiate the effects of sedatives, hypnotics, antihistamines and alcohol.

Use in pregnancy and lactation:
Although there is no evidence of any teratogenic effect, recommendation for Ketotifen in pregnancy cannot be given. Ketotifen is excreted in breast milk; therefore mothers receiving Ketotifen should not breast feed.

Side effects:
Sedation, dry mouth and dizziness may occur at the beginning of treatment, but usually disappear spontaneously with continued medication. Symptoms of CNS stimulation, such as excitation, irritability, insomnia and nervousness have been observed particularly in children.

Overdose:
The reported features of overdose include confusion, drowsiness, nystagmus, headache, disorientation, tachycardia, hypotension, reversible coma; especially in children, hyperexcitability or convulsions. Bradycardia and
respiratory depression should be watched for. Treatment with activated charcoal should be considered if the
overdose has been taken within approximately one hour. If necessary, symptomatic treatment and monitoring of
the CV system are recommended; if excitation is present, short acting barbiturates or benzodiazepines may be
given.

Pharmaceutical precautions
Store in a cool and dry place, protected from light.

এই পাতাটি ৫৪৪ বার দেখা হয়েছে